{"name":"Abraxis BioScience","permalink":"abraxis-bioscience","crunchbase_url":"http://www.crunchbase.com/company/abraxis-bioscience","homepage_url":"http://www.abraxisbio.com/","blog_url":"","blog_feed_url":"","twitter_username":"","category_code":"biotech","number_of_employees":null,"founded_year":2007,"founded_month":null,"founded_day":null,"deadpooled_year":null,"deadpooled_month":null,"deadpooled_day":null,"deadpooled_url":null,"tag_list":"","alias_list":"","email_address":"investorrelations@abraxisbio.com","phone_number":"(310) 405-7522","description":"","created_at":"Thu Jul 01 01:43:16 UTC 2010","updated_at":"Wed May 23 08:07:30 UTC 2012","overview":"<p>Abraxis BioScience, Inc., a biotechnology company, engages in the discovery, development, and delivery of next-generation therapeutics and core technologies that offer treatments for cancer and other critical illnesses. </p>\n\n<p>The company principally offers Abraxane, a nanoparticle chemotherapeutic compound that is based on its proprietary tumor targeting nab technology platform for the treatment of metastatic breast cancer. </p>\n\n<p>Its other clinical product candidates include ABI-008, a phase II solvent-free and Tween-free nanometer-sized form of docetaxel for the treatment of hormone refractory prostate cancer and metastatic breast cancer; ABI-009, a phase I nab-rapamycin mTOR inhibitor for the treatment of solid tumors; ABI-010, a polyketide inhibitor of heat shock protein 90 for the treatment of multiple cancers; ABI-011, a thiocolchicine dimer for microtubule destabilization and the disruption of topoisomerase-1 activity; and Coroxane, a phase II nanometer-sized paclitaxel for coronary restenosis and peripheral artery restenosis. Abraxis BioScience has strategic relationships with Taiho Pharmaceutical Co., Ltd.; Biocon Limited; Green Cross Corporation; Specialised Therapeutics of Australia, Pty Ltd.; and ProMetic Life Sciences Inc. </p>\n\n<p>The company was formerly known as New Abraxis, Inc. and changed its name to Abraxis BioScience, Inc. in November 2007. Abraxis BioScience, Inc. is based in Los Angeles, California.</p>\n\n<p>In 2010, Abraxis BioScience was acquired by <a href=\"/company/celgene\" title=\"Celgene Corp\" rel=\"nofollow\">Celgene Corp</a>.</p>","image":{"available_sizes":[[[134,76],"assets/images/resized/0009/2195/92195v1-max-150x150.jpg"],[[134,76],"assets/images/resized/0009/2195/92195v1-max-250x250.jpg"],[[134,76],"assets/images/resized/0009/2195/92195v1-max-450x450.jpg"]],"attribution":null},"products":[],"relationships":[{"is_past":false,"title":"Executive Chairman & CEO","person":{"first_name":"Patrick","last_name":"Soon-Shiong","permalink":"patrick-soon-shiong","image":null}},{"is_past":false,"title":"Senior Vice President Finance","person":{"first_name":"Mitchell","last_name":"Fogelman","permalink":"mitchell-fogelman","image":null}}],"competitions":[],"providerships":[],"total_money_raised":"$0","funding_rounds":[],"investments":[],"acquisition":{"price_amount":2900000000,"price_currency_code":"USD","term_code":null,"source_url":"http://www.fiercebiotech.com/story/celgene-strikes-2-9b-deal-acquire-abraxis/2010-06-30?utm_medium=rss&utm_source=rss","source_description":"Celgene strikes $2.9B deal to acquire Abraxis","acquired_year":2010,"acquired_month":6,"acquired_day":30,"acquiring_company":{"name":"Celgene","permalink":"celgene","image":{"available_sizes":[[[113,99],"assets/images/resized/0006/8834/68834v1-max-150x150.png"],[[113,99],"assets/images/resized/0006/8834/68834v1-max-250x250.png"],[[113,99],"assets/images/resized/0006/8834/68834v1-max-450x450.png"]],"attribution":null}}},"acquisitions":[],"offices":[{"description":"","address1":"11755 Wilshire Blvd.","address2":"Suite 2000","zip_code":"90025","city":"Los Angeles","state_code":"CA","country_code":"USA","latitude":null,"longitude":null}],"milestones":[],"ipo":null,"video_embeds":[],"screenshots":[{"available_sizes":[[[150,111],"assets/images/resized/0009/2194/92194v1-max-150x150.jpg"],[[250,185],"assets/images/resized/0009/2194/92194v1-max-250x250.jpg"],[[450,333],"assets/images/resized/0009/2194/92194v1-max-450x450.jpg"]],"attribution":null}],"external_links":[]}